- Home
- COGT vs YRD Comparison
COGT vs YRD Comparison
Compare COGT & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- YRD
- Stock Information
- Founded
- COGT 2014
- YRD 2012
- Country
- COGT United States
- YRD China
- Employees
- COGT N/A
- YRD N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- YRD Finance: Consumer Services
- Sector
- COGT Health Care
- YRD Finance
- Exchange
- COGT Nasdaq
- YRD Nasdaq
- Market Cap
- COGT 545.3M
- YRD 495.5M
- IPO Year
- COGT 2018
- YRD 2015
- Fundamental
- Price
- COGT $4.37
- YRD $5.70
- Analyst Decision
- COGT Buy
- YRD
- Analyst Count
- COGT 7
- YRD 0
- Target Price
- COGT $14.17
- YRD N/A
- AVG Volume (30 Days)
- COGT 1.7M
- YRD 196.4K
- Earning Date
- COGT 05-06-2025
- YRD 03-20-2025
- Dividend Yield
- COGT N/A
- YRD 6.76%
- EPS Growth
- COGT N/A
- YRD N/A
- EPS
- COGT N/A
- YRD 2.48
- Revenue
- COGT N/A
- YRD $795,426,969.00
- Revenue This Year
- COGT N/A
- YRD N/A
- Revenue Next Year
- COGT N/A
- YRD N/A
- P/E Ratio
- COGT N/A
- YRD $2.30
- Revenue Growth
- COGT N/A
- YRD 18.59
- 52 Week Low
- COGT $3.72
- YRD $4.12
- 52 Week High
- COGT $12.61
- YRD $9.20
- Technical
- Relative Strength Index (RSI)
- COGT 34.56
- YRD 41.70
- Support Level
- COGT $4.12
- YRD $5.56
- Resistance Level
- COGT $5.09
- YRD $5.95
- Average True Range (ATR)
- COGT 0.54
- YRD 0.45
- MACD
- COGT -0.02
- YRD -0.08
- Stochastic Oscillator
- COGT 23.90
- YRD 36.50
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an advanced, AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.